Phase I Clinical Trial of Nasal Spray in Treating Patients With Recurrent Glioblastoma, Gliosarcoma, Glioma
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 12 Jan 2018
At a glance
- Drugs Axitinib (Primary) ; Pazopanib (Primary) ; Sunitinib (Primary)
- Indications Glioblastoma; Glioma; Gliosarcoma
- Focus Therapeutic Use
- 09 Jan 2018 Planned initiation date changed from 1 Dec 2017 to 1 Feb 2018.
- 07 Dec 2017 Planned initiation date changed from 1 Oct 2017 to 1 Dec 2017.
- 07 Dec 2017 Status changed from suspended to not yet recruiting.